Journal
FEBS JOURNAL
Volume 279, Issue 2, Pages 223-233Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1742-4658.2011.08417.x
Keywords
bispecific diabody; cancer immunotherapy; CD16; epidermal growth factor receptor; humanization
Categories
Funding
- Ministry of Education, Science, Sports, and Culture of Japan
- New Energy and Industrial Technology Development Organization of Japan
- National Institute of Biomedical Innovation
- Grants-in-Aid for Scientific Research [23791512, 23790136, 23650227, 23686118] Funding Source: KAKEN
Ask authors/readers for more resources
We previously reported the construction and activity of a humanized, bispecific diabody (hEx3) that recruited T cells towards an epidermal growth factor receptor (EGFR) positive tumor. Herein, we describe the construction of a second functional, fully humanized, anti-EGFR bispecific diabody that recruits another subset of lymphocyte effectors, the natural killer cells, to EGFR-expressing tumor cells. After we confirmed that an anti-EGFR x anti-CD16 bispecific diabody (Ex16) consisting of a previously humanized anti-EGFR variable fragment (Fv) and a mouse anti-CD16 Fv had growth inhibitory activity, we designed a humanized anti-CD16 Fv to construct the fully humanized Ex16 (hEx16). However, the humanized form had lower activity for inhibition of cancer growth. To restore its growth inhibitory activity, we introduced mutations into the Vernier zone, which is located near the complementarity-determining regions and is involved in their binding activity. We efficiently prepared 15 different hEx16 mutants by expressing each chimeric single-chain component for hEx16 separately. We then used our in vitro refolding system to select the most functional mutant, which had a growth inhibitory effect comparable with that of the commercially available chimeric anti-EGFR antibody, cetuximab. Our refolding system could aid in the efficient optimization of other proteins with heterodimeric structure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available